Clinical Infectious Diseases

Clinical Infectious Diseases
Title	Clinical Infectious Diseases
Discipline	Infectious diseases
Abbreviation	Clin. Infect. Dis.
Publisher	Oxford University Press
Country	United States
History	1989–present
Frequency	Monthly
Impact	10.0

Contents

Clinical Infectious Diseases is a peer-reviewed medical journal focusing on infectious diseases, antimicrobial therapy, epidemiology, and clinical management. Established in 1989 and published by Oxford University Press, it serves clinicians, researchers, and public-health professionals associated with institutions such as the Centers for Disease Control and Prevention, World Health Organization, and academic centers like Johns Hopkins Hospital and Massachusetts General Hospital. The journal frequently features contributions from investigators affiliated with organizations including the National Institutes of Health, Harvard Medical School, and the University of Oxford.

Overview

Clinical Infectious Diseases publishes original research, reviews, and practice guidelines that intersect with entities such as the Infectious Diseases Society of America, European Centre for Disease Prevention and Control, and national agencies like Public Health England and the Robert Koch Institute. The journal's scope spans pathogens studied at laboratories such as the Centers for Disease Control and Prevention and the Pasteur Institute, and includes outbreaks investigated by teams from Médecins Sans Frontières, Wellcome Trust, and university research groups at Stanford University and University of California, San Francisco. Influential articles often inform policies at bodies such as the Gates Foundation, World Bank, and regional health ministries in countries like India, Brazil, and South Africa.

Articles address etiologic agents ranging from viruses studied at the National Institute of Allergy and Infectious Diseases to bacteria characterized in collections at the American Type Culture Collection and fungi researched at institutions like the Fungal Research Trust. Case series and mechanistic studies link pathogen biology to host responses involving pathways investigated at Salk Institute and molecular techniques developed at laboratories including Cold Spring Harbor Laboratory and EMBL. Pathogenesis reports often cite comparative analyses involving pathogens such as Mycobacterium tuberculosis, Human immunodeficiency virus, Influenza A virus, SARS-CoV-2, Staphylococcus aureus, Candida albicans, and zoonoses traced to reservoirs like Rabbits, Bats, and Swine in field studies led by teams from Smithsonian Institution and WCS (Wildlife Conservation Society).

Clinical descriptions in the journal synthesize case reports from hospitals such as Mayo Clinic and Cleveland Clinic with diagnostic algorithm development by groups at Karolinska Institute and Imperial College London. Diagnostic methods cover assays validated by the Food and Drug Administration, imaging protocols influenced by research at Massachusetts General Hospital Radiology Department, and point-of-care tests deployed by Clinton Health Access Initiative and PATH. Syndromic presentations include respiratory failure as seen in 1918 influenza pandemic analyses, febrile illnesses reminiscent of outbreaks like Ebola virus epidemic in West Africa and Zika virus epidemic, and antimicrobial-resistant infections analogous to crises described for Methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis.

Therapeutic content integrates randomized trials conducted at centers including Vanderbilt University Medical Center and University of Toronto with guideline frameworks from the World Health Organization and specialty societies like the European Society of Clinical Microbiology and Infectious Diseases. Antimicrobial stewardship programs reported in the journal reference interventions implemented at institutions such as Guy's and St Thomas' NHS Foundation Trust and Johns Hopkins Hospital, and pharmacologic studies often involve drugs approved by the European Medicines Agency and the Food and Drug Administration. Surgical and adjunctive strategies recur in articles tied to outcomes in cohorts from Karolinska University Hospital and transplant services at Cleveland Clinic.

Prevention-focused research connects vaccine trials sponsored by entities such as Gavi, the Vaccine Alliance, Bill & Melinda Gates Foundation, and manufacturers represented in reports from GlaxoSmithKline and Pfizer. Studies influence policy at public health authorities including Centers for Disease Control and Prevention and National Health Service (England), and examine programmatic interventions in countries like Kenya, Nigeria, and Bangladesh. Surveillance and outbreak response articles highlight collaborations with World Health Organization emergency teams, regional laboratories in networks coordinated by European Centre for Disease Prevention and Control, and international consortia such as Coalition for Epidemic Preparedness Innovations.

The journal chronicles emerging threats and research frontiers addressed by consortia including COVID-19 Vaccine Global Access Facility, HIV Vaccine Trials Network, and university collaborations between University of Cambridge and University of Oxford. Topics include genomic epidemiology using platforms like Wellcome Sanger Institute and bioinformatics methods from groups at Broad Institute, antimicrobial-resistance modeling tied to outputs from RAND Corporation and Institute for Health Metrics and Evaluation, and One Health research involving Food and Agriculture Organization and World Organisation for Animal Health. Cross-disciplinary studies link clinical insights to global initiatives such as the Sustainable Development Goals and health security frameworks promoted by the United Nations.

Category:Infectious disease journals